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The hasubanan akaloids are a large collection of natural products isolated from several
medicinal herbs that are used in traditional Chinese medicine.[i] Members of this family
share a common aza-[4.4.3]-propellane core, but vary substantially in the oxidation patterns
of their peripheral structure. The least oxidized hasubanans are 8-demethoxyrunanine (1)[ii]
and cepharamine (3);[iii] runanine (2),[iv] aknadinine (4),[v] and hasubanonine (5)[vi] are the
result of further oxidation at C8 (Figure 1). These compounds are closely related to an
isomeric family of natural products, the cepharatines (7–10), which were isolated in 2011
from S. cepharantha, the same plant from which cepharamine (3) was isolated.[vii] The
structural similarities between the hasubanans and the cepharatines have led to the
hypothesis that both arise biosynthetically from common precursors. For example, 3, 7, and
8 are proposed to derive from sinoacutine (11),[vii, viii] a compound related, though
antipodal, to morphine. Indeed, due to the topographical similarities between compounds 1–
5 and morphine, there is speculation that the unnatural enantiomers of the hasubanans may
exhibit analgesic properties.[ix]
The hasubanan alkaloids have been the subject of research by a number of synthetic groups
over the past forty years. Although several hasubanans were prepared by total synthesis in
racemic form in the early 1970s,[x, xi] the enantioselective chemical synthesis of this family
of compounds has proven far more challenging. The first enantioselective total synthesis of
a hasubanan alkaloid was the 21-step synthesis of cepharamine (3) reported by Schultz and
Wang in 1998.[xii, xiii] As part of a program targeting the total syntheses of several alkaloid
natural products, we sought to develop a unified strategy for the enantioselective preparation
of the hasubanan and cepharatine alkaloids. From the outset, the objective was to develop a
synthetic approach that could provide access to any member of the hasubanan alkaloids,
starting with the least oxidized members 1 and 3. Following a plan inspired by nature,[xiv]
we envisioned preparing the appropriate aza-propellane skeleton, and then systematically
introducing peripheral oxidation as dictated by the target compound. Ideally, the proposed
aza-propellane intermediates would also be suited for conversion to the corresponding
cepharatine natural products. In this communication, we report our preliminary results that
establish the viability of this approach through short and enantioselective total syntheses of
the natural products 8-demethoxyrunanine (1) and cepharatines A (7), C (8) and D (10).
*Prof. S. E. Reisman, Fax: (+), reisman@caltech.edu, Homepage: http://reismangroup.caltech.edu.
Supporting information for this article is available on the WWW under http://www.angewandte.org or from the author.
NIH Public Access
Author Manuscript
Angew Chem Int Ed Engl. Author manuscript; available in PMC 2012 December 12.
Published in final edited form as:
Angew Chem Int Ed Engl. 2011 September 26; 50(40): 9447–9451. doi:10.1002/anie.201104487.
$watermark-text
$watermark-text
$watermark-text
In accord with our plan, both the hasubanans and cepharatines were anticipated to arise from
an aza-propellane intermediate of the general structure 12 (Figure 2). This aza-propellane
intermediate was foreseen to derive from dihydroindolone 13 by an intramolecular Friedel-
Crafts-type alkylation. In a following step, oxidation and rearrangement of 12 could then
give rise to 17, bearing the cepharatine framework. As an important part of our strategy, it
was anticipated that the arene oxidation patterns of either runanine/cepharatine D or
cepharamine/cepharatine A could be generated from 13 by simply controlling the site of
electrophilic aromatic substitution in the Friedel-Crafts reaction. Literature precedent
suggested that the intrinsic selectivity of the dimethoxy substrate 13a (R1 = H, R2 = OMe,
R3 = H) would favor reaction at the less sterically encumbered para-position, to provide the
product with the runanine oxidation pattern (12a, R1 = H, R2 = OMe, R3 = H).[xv]
Alternatively, we anticipated generating the aza-propellane bearing the cepharamine
oxidation pattern found in 12b (R1 = OTMSE, R2 = H, R3 = H) by installing an appropriate
blocking group in the cyclization substrate (e.g. 13b, R1 = OTMSE, R2 = H, R3 = Br).
To implement the synthetic plan detailed above, the enantioselective preparation of
dihydroindolones 13a/13b would be required. We recently reported the preparation of
benzoquinone monoketal-derived N-tert-butanesulfinimine 14, which undergoes highly
diastereoselective 1,2-addition with a variety of organometallic reagents.[xvi] Based on this
report, we expected dihydroindolones 13a/13b to be accessible from 14 by a short sequence
involving Grignard addition, N-methylation, and pyrrolidine formation.
In the forward sense, our synthesis began with N-tert-butanesulfinimine 14,[xvi] easily
prepared on multigram scale in two steps from commercially available 2-bromo-4-
methoxyphenol (Scheme 1). Addition of Grignard reagent 20a at low temperatures followed
by in situ N-methylation provided sulfinamide 21 in 77% yield, which was isolated as a
single diastereomer. Analysis of the crude reaction mixture determined that the 1,2-addition
proceeded in 96:4 dr. Notably, hydrolysis of the dimethyl acetal occurs during the mildly
acidic workup without detectable quantities of undesired dienone-phenol rearrangementxvii
products.
Construction of the required pyrrolidine ring was accomplished by a three step sequence that
began with Pd-catalyzed cross coupling between vinyl bromide 21 and ethoxy vinylstannane
23 to yield enol ether 24 in 90% yield (Scheme 1). After considerable experimentation, it
was found that brief exposure of 24 to 1M HCl in THF at 0 °C cleaved the sulfinamide and
promoted intramolecular condensation to provide the corresponding indolone.[xviii]
Chemoselective mono-reduction of the indolone was achieved using sodium borohydride
and acetic acid, furnishing the desired dihydroindolone 13a in 96% yield over two steps.
With an eye toward preparing cepharamine (3) or cepharatines A (7) and C (8),
dihydroindolone 26, bearing a differentially protected arene, was prepared through an
analogous route from 20b.
With access to dihydroindolones 13a and 26, our efforts turned to implementing the key
intramolecular Friedel-Crafts reactions (Scheme 2). A small screen of Lewis acids revealed
that exposure of dienone 13a to BF3•Et2O promoted cyclization; however, the yield of
recovered 12a was moderate.[xix] Thus, we turned to the use of strong Brønsted acids, and
were pleased to find that use of excess TfOH in dichloromethane[xx] smoothly promoted
cyclization exclusively at C14, delivering the desired propellane 12a in 97% yield. It is
proposed that selective addition to the trisubstituted alkene, in preference to the less-
hindered disubstituted alkene, results from the formation of a discrete, protonated
intermediate that favors the more stable, tertiary carbocation at C14. Given our desire to
access the cepharamine oxidation pattern, the TMSE-protected substrate 26 was brominated
and exposed to the TfOH cyclization conditions in situ to furnish aza-propellane 30.
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Monitoring this reaction revealed that cleavage of the TMSE group is rapid, and cyclization
of the phenol occurs upon warming the reaction to room temperature.
Having developed an efficient and unified approach to aza-propellanes bearing either the
runanine or cepharamine oxidation patterns, we turned to the remaining challenge of
adjusting the oxidation level of C7 to that found in both 1 and 3. To this end, exploratory
studies were carried out using 12a (Scheme 3). We were pleased to find that exposure of
enone 12a to standard nucleophilic epoxidation conditions[xxi] (H2O2, LiOH, MeOH)
followed by heating to 50 °C provided 8-demethoxyrunanine (1), albeit in low yield (10–
15% yield). Presuming that 1 was formed via the epoxide, we hoped to optimize the yield of
the overall process by isolating this intermediate. Ultimately, it was determined that the
combination of t-butylhydroperoxide (TBHP) and Triton B in THF provided clean
conversion to epoxide 27. However, attempts to purify the reaction mixture by silica gel
chromatography led to isolation of epoxide 27 along with hemiaminal 28, a compound
bearing the cepharatine framework.[xxii] One proposed mechanism for the formation of 28
begins with nitrogen-assisted opening of the epoxide followed by β-elimination of the
aziridinium to give enol 15 (see Figure 2, R1 = H, R2 = OMe). Enol-facilitated elimination
of the amine and intramolecular aminal formation would provide 28. This rearrangement can
be suppressed by purification of epoxide 27 using Florisil. Though pleased by our ability to
generate the cepharatine framework from the hasubanan core, we continued to explore
conditions for the formation of 1. After an extensive survey of reaction conditions,[xxiii] it
was discovered that use of tetrabutylammonium methoxide[xxiv] in THF at 50 °C for 12 h
provided the natural product 8-demethoxyrunanine (1) in 68% yield. Using this sequence, 1
is prepared in only nine steps and in 19% overall yield from commercially available phenol
18.
Following completion of the synthesis of 8-demethoxyrunanine (1), attention turned to
improving the yield of hemiaminal 28 and elaborating it to cepharatine D (10). After
screening several reaction parameters, it was determined that epoxidation of 12a followed
by prolonged exposure to silica gel provided direct access to aminal 28 in 76% yield from
propellane 12a (Scheme 3). Desaturation of aminal 28 was carried out by deprotonation with
excess KHMDS at −78 °C followed by addition of N-t-butylbenzenesulfinimidoyl chloride
(29),[xxv] providing cepharatine D (10) in 9 steps and 22% overall yield from 18.
Having converted propellane 12a to the natural products 1 and 10, we sought to carry out a
similar reaction sequence to convert bromo-propellane 30 to the corresponding compounds
cepharamine (3) and cepharatine A (7) (Scheme 4). In contrast to the epoxidation of 12a,
epoxidation of enone 30 proceeded sluggishly, and despite considerable attempts at
optimization, epoxide 31 was isolated in only 40% yield.
Efforts to drive the epoxidation reaction to completion were complicated by competitive
oxidative rearrangement of the epoxide product, resulting in formation of a lactone
byproduct.[xix] Unfortunately, exposure of epoxide 31 to Bu4NOMe in THF (identical
conditions to those utilized to convert 27 to 1) provided only trace amounts of enol ether 32,
as detected by 1H NMR analysis of the crude reaction mixture. Reasoning that deprotonation
of the phenolic O-H might contribute to the poor reactivity, several protected variants of 30
were prepared (e.g. Me-, MOM-, allyl-, and Bn-protected phenols).
Whereas the epoxidation step proceeded with improved efficiency for these substrates,
exposure of the epoxides to a variety of methoxide sources still provided prohibitively low
quantities of the desired methyl enol ethers (analogous to 32). These studies illustrate how
subtle perturbations in the arene oxidation patterns can strikingly alter the reactivity of the
aza-propellane framework. Similarly, treatment of enone 30 under the tandem epoxidation/
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rearrangement conditions identified for the conversion of 12a to 28 provided lower yields of
the corresponding hemiaminal (33) (Scheme 4). However, we were pleased to find that
selective hydrodebromination of the aryl bromide followed by treatment with PhI(OAc)2
and base cleanly provided cepharatine A (7) in good yield over two steps.[xxvi] Finally,
cepharatine A could be converted to cepharatine C (8) by exposure to methanol under mildly
acidic conditions. Using this reaction sequence, 7 and 8 could be prepared in 10 and 11 steps
and each in 10% overall yield, respectively, from commercially available starting materials.
In conclusion, a unified synthetic strategy has resulted in the short, enantioselective total
syntheses of 8-demethoxyrunanine (1) and cepharatines A (7), C (8), and D (10). Key to this
synthetic strategy was the use of benzoquinone monoketal-derived N-tert-butanesulfinimine
14 to prepare 4-aminocyclohexadienones 21 and 22 with excellent stereocontrol. Depending
on the reaction sequences, either the runanine or cepharamine arene oxidation patterns could
be achieved by way of a regioselective intramolecular Friedel-Crafts-type alkylation.
Moreover, it was shown that the hasubanan framework rearranges under mild conditions
providing access to the cepharatine natural products. Ongoing studies in our laboratory are
focused on the development of oxidation strategies to access cepharamine and the more
oxidized members of the hasubanans, as well as the application of this general approach to
the synthesis of the related acutumine[xxvii] family of alkaloids.
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Figure 1.
Representative members of the hasubanan and cepharatine alkaloids.
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Figure 2.
Synthetic plan.
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Scheme 1.
Synthesis of enantioenriched dihydroindolones 13a and 26.
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Scheme 2.
Preparation of aza-propellanes 12a and 30.
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Scheme 3.
Enantioselective synthesis of 8-demethoxyrunanine (1) and cepharatine D (10).
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Scheme 4.
Enantioselective synthesis of cepharatines A (7) and C (8)
Chuang et al. Page 12
Angew Chem Int Ed Engl. Author manuscript; available in PMC 2012 December 12.
$watermark-text
$watermark-text
$watermark-text
